“Reluctant activist” investor George Haywood has a new biotech target in his sights. Sign Up For Our Free Newsletter George Haywood has an unusual career and socially conscious approach to activism. After successfully brokering in the Sirius / XM satellite deal, where he sat on the board for a time, and engaging in activist maneuvers with Sarepta Therapeutics Inc (NASDAQ:SRPT), investing when the biotech firm had a mere $150 million valuation and watching it grow to over $1 billion in value as it helps solve a key medical problem, the investor now has his sights on krill oil. Neptune Technologies,…
On This Page
This content is exclusively for paying members of Hedge Fund Alpha
Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha
Don’t have an account?
Subscribe now and get 7 days free!
